| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |